Skip to Content

HKEX Biotech Summit 2018

Updated: 22 Mar 2018

HKEX Biotech Summit 2018

** Watch all the highlights from the HKEX Biotech Conference 2018

Hong Kong Exchanges and Clearing Limited (HKEX) proudly presents the inaugural HKEX Biotech Summit 2018, an industry conference dedicated to industry professionals to network, exchange insights and experience, and work together to promote the biotech funding ecosystem in Hong Kong.

HKEX has published a public consultation paper seeking public feedback on the proposed new rules to accommodate the listings of companies from emerging and innovative sectors, with a new chapter focusing on the listing of pre-revenue biotech issuers. The proposed new chapter will widen market access for these companies to create a more vibrant marketplace in Hong Kong. For more information, please refer to the link here.

Summit highlights include:

  • Discussions around the newly proposed pre-revenue chapter and its impact on the biotech and life sciences industries
  • Discover the latest developments in the biotech ecosystem and industry trends both globally and in China
  • Connect with senior executives at biotech companies, the investment community, as well as investment banks, accounting and other marketing practitioners in the biotech funding ecosystem.
Event Details: By Invitation Only
Date 22 March 2018 (Thursday)

Location

HKEX Connect Hall

1/F, One and Two Exchange Square, Central, Hong Kong

Language
English and Mandarin (simultaneous translation available)
Dress Code
Business Attire

 

Tentative Programme
Time Topic
08:30 Guest Registration

09:00

 

Welcome Address

Chung Kong CHOW, Chairman, HKEX Group

09:05

 

Opening Remarks

Paul CHAN, Financial Secretary, Government of the Hong Kong Special Administrative Region

09:15

 

Remarks

Carlson TONG, Chairman, Securities and Futures Commission

09:20

 

Remarks

Ashley ALDER, Chief Executive Officer, Securities and Futures Commission

09:25

Keynote

Charles LI, Chief Executive, HKEX Group

10:00

 

Keynote: Global Biotech Landscape and Trends

James GREENWOOD, President and CEO, Biotechnology Innovation Organization

10:30 Coffee Break

10:50

 

Keynote: Refining Evaluation Criteria and Accelerating Pharmaceutical Approval

Ruyi HE, Chief Scientist, China Food and Drug Administration Center for Drug Evaluation

11:25

 

Keynote: Development of the Mainland Biotech Industry: Looking into the Future

Ruilin SONG, Executive President, China Pharmaceutical Innovation and Research Development Association (PhIRDA)

12:00 Networking Lunch

13:30

Panel 1: Has the East Caught Up to the West in Biotech Development?

Hosted by BayHelix Group (BayHelix)

Moderator: Wenseng PAN, Board Director, BayHelix; Partner, Sidley Austin

Panelists:

  • Jun BAO, Board Director, BayHelix; Senior Vice President and Chief Business Officer, acting CFO, Shenogen Pharma Group
  • Bin LI, Partner and Managing Director, Ally Bridge Group; CEO and CIO, Ally Bridge LB Healthcare Fund
  • Marietta WU, Managing Director, Quan Venture Fund; Co-Founder, Zai Lab
  • Dan ZHANG, Chairman, Fountain Medical Group

14:20

 

Panel 2: Does China Have What it Takes to Lead the World in terms of Innovation?

Hosted by PhIRDA

Moderator: Lawrence TIAN, Founding Partner, YuanMing Capital

Panelists:

  • Daniel LEE, Head of Biomedical Technology Cluster, Hong Kong Science and Technology Parks
  • Ting XU, President and CEO, Alphamab
  • Dajun YANG, Co-Founder, Chairman and CEO, Ascentage Pharma
  • Michael YU, Chairman and CEO, Innovent Biologics
15:10 Coffee Break

15:30

 

Panel 3: When is it the Right Time to Capitalize on PE Investments or Go Public?

Hosted by China HealthCare Investment 50 Forum

Moderator: Feng DENG, Founding Managing Director, Northern Light Venture Capital

Panelists:

  • Daqing CAI, Managing Director, Legend Capital
  • Kevin CHEN, Founding Partner, Biotrack Capital
  • Yusheng HAN, CEO, Burning Rock Dx
  • Frank JIANG, Managing Partner, CStone Pharmaceuticals
  • John ZHU, Partner, 6 Dimensions Capital

16:20

 

Panel 4: A CEO Dialogue

Hosted by Charles LI, Chief Executive, HKEX Group

Panelists:

  • Chris CHEN, CEO, WuXi Biologics
  • Jun WANG, Founder and CEO, iCarbonX; Chairman, AOBiome
  • Xiaodong WANG, Founder and Chairman, BeiGene
17:15 Closing Remarks
17:30 Networking Cocktail

Note: The Programme is subject to further changes without prior notice. Please check back again for latest information.

For enquiries, please contact Organising Committee of the HKEX Biotech Summit 2018 at biosummit@hkex.com.hk.

loading